Searched for
MEDICARE DRUGS
How many Americans can afford high-quality healthcare? A new poll finds the number has fallenAmericans face growing challenges affording healthcare. New data reveals a significant drop in those able to manage medical costs and acces...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Social Security May 20, 2026 payments: Who gets SSA and SSI checks this week, and how much amid inflation?Social Security May 20, 2026 payments are arriving this week for Americans born between the 11th and 20th. Many retirees, SSDI recipients, ...
- The Iran war is now changing your Social Security check; here's the new 2027 COLA numberSocial Security COLA update 2027: Gas prices in America have surged above $4.10 per gallon, up sharply from $3.17 last year, and the impact...
- Most married couples are leaving Social Security money on the table — here's how to claim it allSocial Security benefits for married couples are becoming one of America’s biggest retirement conversations in 2026. The average dual-incom...
- Donald Trump's drugmaker deals may save economy $529 billion over 10 years: White HousePresident Trump's administration projects significant savings from deals with drug companies. These agreements aim to lower US prescription...
- Why is the 2026 Social Security 2.8% COLA failing against 3.3% inflation? Is your retirement check shrinking?Social Security COLA 2026 Inflation Gap: Why 2.8% Increase Trails 3.3% Senior Inflation. The 2.8% Social Security COLA for 2026 is failing....
- Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiativeRegeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted d...
- US to loosen marijuana rules in major shift for $47 billion industryThe United States Department of Justice is easing rules on certain marijuana items. The drug will be reclassified as less dangerous. This s...
- Medicare alert: Miss today’s deadline and you could face months of higher costsMedicare Advantage deadline ends March 31, and missing it may lead to higher health costs for months. People can still switch plans or retu...
- Will you have to pay Medical Surcharge next year? How much is IRMAA, and how to avoid or reduce it?The Social Security Administration (SSA) bases Medicare premiums on tax returns from two years earlier, meaning your 2024 income will deter...
- US court rejects Novo Nordisk's challenge to Medicare drug pricing planA federal appeals court has rejected Novo Nordisk's challenge to Medicare's program allowing drug price negotiations. This ruling is the la...
- Could a new policy change the way Americans pay for drugs forever? Trump's new plan revealedThe Trump administration is exploring a policy to link US drug prices to those of other developed nations. This move is causing concern in ...
- Trump seeks to lower drug prices through medicare and some importsPresident Trump signed an executive order targeting drug prices, including potential state importation from Canada. While some directives a...
- Funding freeze halted, White House preps for legal battleThe White House plans to contest a court ruling that blocked part of the Trump administration's directive to pause federal financial aid. A...
- White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearlyThe Biden administration announced agreements with drug companies to lower the cost of 10 major Medicare medications, potentially saving ta...
- US names first 10 drugs for Medicare price negotiationThe Biden administration has released a list of 10 prescription medicines that will be subject to price negotiations by the U.S. Medicare h...
- Shilpa Medicare gets tentative American health regulator nod for Apremilast tabletsThe company has received tentative approval from US Food and Drug Administration for its abbreviated new drug application (ANDA) Apremilast...
- Shilpa Medicare launches cancer drug at monthly therapy cost of Rs 6,440The drug substance patent on Dasatinib was owned by Bristol-Myers-Squibb and had expired on 12 April 12, 2020. The current monthly therapy ...
- US Medicare could have saved $1 billion by substituting branded drugs, says studyThe revelation is significant for India since Indian pharma companies supply 40 per cent of generic drugs consumed in the US.
Load More
